Kronik hepatit C tedavisinde yanıtı belirlemede TNF-a(-308,-238), IL-10(-1082,-627) ve TGFB1+25 gen polimorfizminin rolü

dc.contributor.advisor	Yurdaydın, Cihan
dc.contributor.author	Aksoy, Burcu
dc.date.accessioned	2020-12-03T11:51:50Z
dc.date.available	2020-12-03T11:51:50Z
dc.date.submitted	2006
dc.date.issued	2018-08-06
dc.identifier.uri	https://acikbilim.yok.gov.tr/handle/20.500.12812/41592
dc.description.abstract
dc.description.abstract		en_US
dc.language	Turkish
dc.language.iso	tr
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.rights	Attribution 4.0 United States	tr_TR
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.subject	Biyoloji	tr_TR
dc.subject	Biology	en_US
dc.subject	Biyoteknoloji	tr_TR
dc.subject	Biotechnology	en_US
dc.title	Kronik hepatit C tedavisinde yanıtı belirlemede TNF-a(-308,-238), IL-10(-1082,-627) ve TGFB1+25 gen polimorfizminin rolü
dc.title.alternative	The role TNF-a(-308,-238), IL-10(-1082,-627) and TGFB1+25 gene polymorphisms in the determination of response to chronic hepatitis C treatment
dc.type	masterThesis
dc.date.updated	2018-08-06
dc.contributor.department	Disiplinlerarası Biyoteknoloji Anabilim Dalı
dc.identifier.yokid	352858
dc.publisher.institute	Biyoteknoloji Enstitüsü
dc.publisher.university	ANKARA ÜNİVERSİTESİ
dc.identifier.thesisid	175906
dc.description.pages	61
dc.publisher.discipline	Diğer

Except where otherwise noted, this item's license is described as info:eu-repo/semantics/embargoedAccess